PTCE Exam Dumps - PTCB CPhT Questions and Answers

Tall Man letteringis amedication safety strategyrecommended by theFDA, ISMP (Institute for Safe Medication Practices), and The Joint Commissiontoprevent medication errorscaused bylook-alike, sound-alike (LASA) drug names.

Thedistinctive portionsof similar drug names are written inuppercase lettersto highlight differences.

Helps pharmacists, technicians, and healthcare professionals distinguish medications that areeasily confuseddue to similar names.

Reduces the risk ofprescription misinterpretationandmedication errorsin pharmacy settings.

How Tall Man Lettering Works:Examples of Tall Man Lettering (ISMP and FDA-Approved List):Regular Name

Tall Man Lettering Version

prednisone

predniSONE

prednisolone

prednisoLONE

hydroxyzine

hydrOXYzine

hydralazine

hydrALAzine

dobutamine

dobutAMINE

dopamine

dopaMINE

A. Highlights the similarities in drug names.→ Incorrect. Tall Man lettering highlightsdifferences, not similarities, toprevent confusion.

B. Ensures all trade names will be capitalized.→ Incorrect. Tall Man lettering applies toboth brand and generic names, but it is used specifically for drugs with look-alike names.

D. Keeps the pharmacy inventory in alphabetic order.→ Incorrect. Inventory order is based onstandard drug names, not Tall Man lettering.

Institute for Safe Medication Practices (ISMP) – Official Tall Man Lettering List.

FDA and The Joint Commission Medication Safety Guidelines.

PTCB PTCE Exam Content Outline – Medication Safety Strategies.

USP <797> and ISMP Guidelines on Look-Alike, Sound-Alike Medications.

Mosby’s Pharmacy Technician: Principles and Practice – Error Prevention Strategies.

Why the Other Answer Choices Are Incorrect:Pharmacy Technician References:Conclusion:Tall Man lettering is anessential tool for pharmacy techniciansto helpreduce medication errorsby drawing attention todifferencesbetweensimilar drug names, ensuringsafer dispensing and administrationof medications.

The prescription forhydroxyzine (25 mg q6h) for hypertensionis likely alook-alike, sound-alike (LASA) medication error, ashydroxyzineis anantihistamineused foranxiety, nausea, and allergiesbutnot for hypertension.

A common LASA confusion is between:

Hydroxyzine (antihistamine, sedative effects, brand names: Vistaril, Atarax)

Hydralazine (antihypertensive, vasodilator, used for hypertension, brand: Apresoline)

Sincehydralazineis used forhypertension, the prescription likely contains anordering errorthat must be clarified with the prescriber.

A. Hydroxyzine requires special handling→ Incorrect; hydroxyzine does not require special handling.

B. The prescription exceeds the maximum recommended daily dose→ Incorrect; hydroxyzine's max daily dose is400 mg/day, and this prescription does not exceed it.

D. Hydroxyzine is subject to a REMS program→ Incorrect; hydroxyzineis not part of a Risk Evaluation and Mitigation Strategy (REMS) program.

Other Answer Choices Explained:References:

FDA & ISMP Look-Alike Sound-Alike (LASA) Drug List

PTCB PTCE Exam Content Outline (Medication Safety & Error Prevention)

Lexicomp Drug Monographs for Hydroxyzine & Hydralazine

Dilution formula:C₁V₁ = C₂V₂

C₁ = 20%, V₁ = 100 mL, C₂ = 2%

(20)(100) = (2)(V₂) → V₂ = 1000 mL(final volume after dilution).

Convert to oz:1000 mL ÷ 59 mL (2 oz) = 16 bottles.

????Reference:PTCE Pharmacy Dilution Calculations, USP <795> Guidelines.

The Master Formulation Record (MFR) is a standardized document that provides step-by-step instructions on how to compound a specificnonsterile preparation.

It includes:

Active and inactive ingredients

Mixing instructions

Equipment needed

Beyond-use dating (BUD)

Storage requirements

Why Other Options Are Incorrect:

A. Medication Guide?❌Intended for patient information, not compounding.

C. Patient Package Insert?❌Explains medication use but doesn’t contain compounding instructions.

D. Safety Data Sheet (SDS)?❌Contains safety and hazard information, not formulation instructions.

????Reference:USP <795> Nonsterile Compounding Standards, PTCB Compounding Study Guide.

Sig Code Breakdown:

2 gtt = 2 drops

OU (oculus uterque) = both eyes

q4-6h = every 4 to 6 hours

p.r.n. = as needed

Why Other Options Are Incorrect:

A. Both ears?❌"AU" (auris uterque) means both ears, NOT both eyes.

B. Right ear?❌"AD" (auris dextra) means right ear.

C. Right eye?❌"OD" (oculus dexter) means right eye.

????Reference:PTCB Approved Sig Code List, ISMP Safe Prescription Writing Guidelines.

Cytoxan (cyclophosphamide)belongs to thechemotherapy agentdrug classification. It is analkylating agentused to treat various types ofcancer, including:

Leukemia

Lymphoma

Breast cancer

Ovarian cancer

It works byinterfering with DNA replication in rapidly dividing cells, preventing cancer growth.

A. ACE inhibitor❌→Incorrect

ACE inhibitors (angiotensin-converting enzyme inhibitors)are used forhypertension and heart failure(e.g., lisinopril, enalapril).

C. Antibiotic❌→Incorrect

Antibioticstreatbacterial infections(e.g., amoxicillin, azithromycin).

D. Narcotic❌→Incorrect

Narcotics (opioids) are pain relievers(e.g., morphine, oxycodone).Cytoxan is not an opioid.

National Cancer Institute (NCI) Drug Dictionary– ClassifiesCytoxan as an alkylating chemotherapy agent.

PTCB PTCE Exam Content Outline– Covers chemotherapy drugs and their classifications.

FDA Drug Classification Guidelines– Lists Cytoxan as acytotoxic antineoplastic (chemotherapy) drug.

Why Not the Other Options?Key References:

Withdrawal occurs when a drug-dependent individual stops taking the drug abruptly, leading to physiological symptoms.

Example:Opioid withdrawal can cause nausea, sweating, and tremors.

Withdrawal differs from addiction, which involvescompulsive drug-seeking behavior.

????Reference:DEA Controlled Substance Abuse Guide, PTCE MedicationSafety Guidelines.

According tofederal law,a reverse distributor must issue a DEA Form 222 (or electronic equivalent) when a pharmacy requests the destruction of a Schedule II controlled substance.

Reverse distributorshandle the return and disposal ofexpired, damaged, or unusable controlled substances.

DEA Form 222 (or CSOS, the electronic equivalent) is required for Schedule II drugs.

Hydrocodone with acetaminophen (e.g., Norco, Vicodin)is aSchedule II controlled substance, requiringDEA Form 222for reverse distribution.

A. Acetaminophen with codeine❌→Schedule III

Does not require DEA Form 222; instead, DEA Form 41 is used for disposal.

C. Promethazine with codeine❌→Schedule V

Lower abuse potential; does not require DEA Form 222.

D. Pseudoephedrine with ibuprofen❌→Not a controlled substance

Pseudoephedrine is regulated under the Combat Methamphetamine Epidemic Act (CMEA), not the DEA controlled substance schedules.

DEA Controlled Substances Act (CSA)– Confirms thatSchedule II drugs require DEA Form 222 for reverse distribution.

PTCB PTCE Exam Content Outline– Covers controlled substances and reverse distribution requirements.

DEA Diversion Control Division Guidelines– Listshydrocodone as a Schedule II drug requiring Form 222 for disposal.

Understanding DEA Form 222 and Reverse Distribution:Why is Hydrocodone with Acetaminophen the Correct Answer?Why Not the Other Options?Key References:

ARisk Evaluation and Mitigation Strategy (REMS)program is required by theFDAfor certain medications that have serious safety concerns, ensuring their risks do not outweigh their benefits.Mycophenolateis subject to a REMS program due to its severe teratogenic effects.

(A) Sertraline❌Not Subject to REMS

Sertraline (Zoloft) is aSelective Serotonin Reuptake Inhibitor (SSRI)used to treat depression and anxiety.

While SSRIs can carry arisk of birth defects (such as persistent pulmonary hypertension in newborns - PPHN),sertraline is not included in the REMS program.

(B) Ondansetron❌Not Subject to REMS

Ondansetron (Zofran) is anantiemeticused to prevent nausea and vomiting.

While some studies suggest a possible increased risk of congenital defects, it isnot part of a REMS program.

(C) Montelukast❌Not Subject to REMS

Montelukast (Singulair) is aleukotriene receptor antagonist (LTRA)used forasthma and allergies.

It has aBoxed Warningfor mental health side effects butis not subject to a REMS program for pregnancy risks.

(D) Mycophenolate✅Correct – Subject to REMS

Mycophenolate (CellCept, Myfortic)is animmunosuppressantused to prevent organ rejection in transplant patients.

It carries ahigh risk of birth defects and miscarriage, making pregnancy preventionmandatorywhile taking the medication.

TheMycophenolate REMS Programrequires:

Mandatory counselingon pregnancy risks

Negative pregnancy testsbefore starting therapy

Use of effective contraceptionbefore, during, and after treatment

FDA REMS Program for Mycophenolate:https://www.mycophenolaterems.com/

FDA REMS Program Overview: https://www.fda.gov/drugs/risk-evaluation-and-mitigation-strategies-rems

PTCB Exam Content Outline – Medication Safety & Risk Management

Analysis of Answer Choices:References for Pharmacy Technicians:

Upon receiving a recall notice, thefirststep a pharmacy technician should take is toverify whether the recalled product is present in the pharmacy’s inventory. This is critical because:

Product Identification– The pharmacy must determine if it has the affected lot numbers, expiration dates, or specific product variations mentioned in the recall notice.

Patient Safety– If the product is in stock, it must be removed from inventory immediately to prevent accidental dispensing.

Regulatory Compliance– TheFDA, manufacturer, or wholesaleroften provides specific instructions for handling recalled medications, and the pharmacy must comply with those guidelines.

FDA Drug Recall Guidelines– Recalls are classified intoClass I, II, and III, and the process requires inventory verification before further actions.

PTCB PTCE Exam Content Outline– The PTCB exam emphasizes medication safety and regulatory compliance, which includes proper handling of recalls.

The Drug Supply Chain Security Act (DSCSA)– This federal law mandates tracking and traceability of pharmaceutical products, reinforcing the importance of inventory checks during recalls.

Pharmacy Policy & Procedures– Most pharmacies followStandard Operating Procedures (SOPs)where verification of stock is the first step before contacting patients or returning products.

Key References:????Why Not the Other Options?

A. Call any affected patients❌→ This step is necessaryafterthe recall is confirmed and documented. If the pharmacy does not have the recalled product, patient notification is unnecessary.

B. Put the recall notice in the inventory technician’s box for processing❌→ Delaying action by simply passing the notice alongwithout verifying stockcan lead to patient harm.

D. Send the product back❌→ While returning recalled products is part of the process, itshould only occur after verification and proper documentation.